Epigenetic and Immunological Features of Bladder Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24129854 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irina Gilyazova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Urology and Clinical Oncology, Bashkir State Medical University, 450008 Ufa, Russia. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of Russian Federation, Bashkir State Medical University Strategic Academic Leadership Program.
Abstract (Originalsprache)
Bladder cancer (BLCA) is one of the most common types of malignant tumors of the urogenital system in adults. Globally, the incidence of BLCA is more than 500,000 new cases worldwide annually, and every year, the number of registered cases of BLCA increases noticeably. Currently, the diagnosis of BLCA is based on cystoscopy and cytological examination of urine and additional laboratory and instrumental studies. However, cystoscopy is an invasive study, and voided urine cytology has a low level of sensitivity, so there is a clear need to develop more reliable markers and test systems for detecting the disease with high sensitivity and specificity. Human body fluids (urine, serum, and plasma) are known to contain significant amounts of tumorigenic nucleic acids, circulating immune cells and proinflammatory mediators that can serve as noninvasive biomarkers, particularly useful for early cancer detection, follow-up of patients, and personalization of their treatment. The review describes the most significant advances in epigenetics of BLCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Urology and Clinical Oncology, Bashkir State Medical University, 450008 Ufa, Russia.
ORCID-Profile: Kadriia Enikeeva, Guzel Rafikova, Dilara Asadullina
Förderung
- Ministry of Health of Russian Federation
- Bashkir State Medical University Strategic Academic Leadership Program
Zitieren
APA
Gilyazova, I., Enikeeva, K., Rafikova, G., Kagirova, E., Sharifyanova, Y., Asadullina, D., & Pavlov, V. (2023). Epigenetic and Immunological Features of Bladder Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129854
Vancouver
Gilyazova I, Enikeeva K, Rafikova G, Kagirova E, Sharifyanova Y, Asadullina D, et al. Epigenetic and Immunological Features of Bladder Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129854
BibTeX
@article{Gilyazova2023,
author = {Gilyazova, Irina and Enikeeva, Kadriia and Rafikova, Guzel and Kagirova, Evelina and Sharifyanova, Yuliya and Asadullina, Dilara and Pavlov, Valentin},
title = {Epigenetic and Immunological Features of Bladder Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24129854}
}
EUVIMED